Group 1 - A new autonomous robotic system for intraocular surgery has been successfully developed by researchers at the Institute of Automation, Chinese Academy of Sciences, which enhances the precision, safety, and consistency of retinal injections while minimizing iatrogenic damage [2] - The GLM-4.7-Flash model has been officially released and open-sourced, featuring a total parameter count of 30 billion and an activation parameter count of 3 billion, providing a new option for lightweight deployment while balancing performance and efficiency [2] - DingTalk, Amap, and Alipay have jointly launched the "AI Travel" product, which includes features like AI printing and AI simultaneous interpretation in its latest version [2] - UCloud has released and open-sourced the OrderWise Agent, a food delivery price comparison AI, which offers two operational modes, including a lightweight design for personal users that does not require MongoDB [2]

Group 1 - The Robot ETF (562500) opened strong but experienced a decline, with a peak increase of 1.26% and a latest price of 1.107 yuan, down 0.45% from the opening price. Among the 66 constituent stocks, 38 showed a decline, with Hongxun Technology dropping by 7.35% [1] - The trading volume of the Robot ETF reached 409 million yuan, with a turnover rate of 1.54%, indicating a high level of trading activity [1] - A new autonomous ophthalmic surgery robot system has been developed by a research team at the Chinese Academy of Sciences, which enhances the precision and safety of retinal injections, minimizing iatrogenic damage [1] Group 2 - The Robot ETF (62500) is the only robot-themed ETF in the market with a scale exceeding 20 billion yuan, covering various segments such as humanoid robots, industrial robots, and service robots, allowing investors to easily access the entire robot industry chain [2] - Following the adjustment of constituent stocks, the humanoid robot content in the index tracked by the Robot ETF has increased to nearly 70%, successfully removing underperforming stocks and including quality ones, achieving a "retain the strong, remove the weak" strategy [2]

Core Viewpoint - The Chinese Academy of Sciences' Institute of Automation has successfully developed an autonomous ophthalmic surgical robot system, demonstrating clinical feasibility, which enhances the precision, safety, and consistency of intraocular injections [1] Group 1: Technology Development - The autonomous ophthalmic surgical robot system can perform subretinal and intravascular injections throughout the entire intraocular space [1] - This technology significantly improves the accuracy and safety of fundus injections, allowing surgeons to focus more on surgical design and supervision tasks [1] Group 2: Research and Publication - The research results have been published in the international academic journal "Science Robotics" [1]

Core Viewpoint - The rapid development and application of artificial intelligence technology have made the research and development of ophthalmic surgical robots a key focus in the industry, aiming to enhance precision and safety in eye surgeries [1][3]. Group 1: Technological Advancements - The Chinese Academy of Sciences' Institute of Automation has successfully developed an autonomous microscopic ophthalmic surgical robot system that has been clinically validated [3]. - This robotic system can autonomously perform subretinal and intravascular injections within the eye, significantly improving the precision, safety, and consistency of fundus injections while minimizing iatrogenic damage [3][4]. Group 2: Research Contributions - The research team has innovatively constructed core algorithm modules for three-dimensional spatial perception, precise cross-scale positioning, and trajectory control during surgeries [4]. - A multi-view spatial fusion method has been proposed to overcome imaging heterogeneity and dynamic spatial misalignment in multimodal intraocular imaging, creating a dynamically updated global 3D map for comprehensive perception of the intraocular region [4]. Group 3: Performance Metrics - In experiments involving retinal and vascular injections in artificial and live animal eyes, the autonomous surgical robot achieved a 100% injection success rate, with average positioning errors reduced by 79.87% compared to manual surgery and 54.61% compared to doctor-assisted robotic surgery [4]. - The research indicates that this development opens a new technological pathway for the autonomy of intraocular surgeries, potentially leading to intelligent and precise upgrades in ophthalmic surgical treatments [4].

显微眼科手术机器人系统进行自主视网膜手术示意图。（中国科学院自动化研究所供图） 记者1月19日从中国科学院自动化研究所获悉，该所研究员边桂彬团队成功研发一款自主显微眼科 手术机器人系统，可在整个眼内空间实现自主的视网膜下注射与血管注射，提高眼底注射的精确性、安 全性，减少医源性损伤。 科研人员介绍，由于眼睛软组织结构精细、操作空间狭小，医生在眼内手术中的手动操作面临着巨 大挑战。自主显微眼科手术机器人系统构建从术中三维空间感知、跨尺度精确定位到轨迹精准控制的核 心算法模块。与医生手动手术及医生操作机器人进行手术相比较，该机器人系统的平均定位误差均大幅 降低，表现出更高的安全性和精准性。 有专家表示，自主手术机器人系统在眼科手术中的应用能够通过更加智能、精准的操作控制提升手 术安全性，为多种眼科疾病的治疗提供新的可能，尤其在远程医疗和极端环境等复杂场景中展现出广阔 的应用潜力。 相关成果已于近日发表于国际学术期刊《科学-机器人学》。 ...

能开展眼科手术的机器人来了。记者1月19日从中国科学院自动化研究所获悉，该所研究团队成功 研发出一款自主显微眼科手术机器人系统，并完成临床可行性验证。该系统能够显著提升眼科手术的精 准度、安全性与稳定性，最大限度减少手术本身对眼部组织的损伤。相关研究成果发表于《科学-机器 人》杂志。 全球视力受损或失明人数已超过22亿，而眼球内部结构极为精细、操作空间极小，传统眼科手术对 医生的经验和稳定性要求极高。该自主机器人系统通过智能、精准地控制，有望大幅提升手术安全水 平，缩短医生培养周期，为多种眼底疾病的治疗提供全新解决方案。 论文通讯作者、中国科学院自动化研究所研究员边桂彬介绍，研究团队通过多视角空间融合方法， 构建了术中动态更新的眼内三维地图，实现了对手术区域的全面感知；运用多传感器数据融合技术，实 现了手术器械从宏观到微观的跨尺度精确定位；并基于多约束优化与人在回路的混合控制，确保了手术 轨迹的精准与安全。 实验表明，该系统在多种眼球模型上的注射成功率达到100%，平均定位误差较医生手动操作降低 约80%，即使与医生操作机器人辅助手术相比，误差也减少约55%，展现出优越的精确性与安全性。 "这项成果为眼科手术 ...

中新 "眼睛是心灵的窗户",在这个软组织结构精细、操作空间狭小的"窗户"上做手术,每一次手动操作都面临 巨大挑战。中国科学院自动化研究所1月19日向媒体通报,该所多模态人工智能系统全国重点实验室边桂 彬研究员团队最新成功研发出一款面向眼内空间的自主显微眼科手术机器人系统,并已验证临床可行 性。 ...

Core Insights - The research team led by Bian Guibin at the Institute of Automation, Chinese Academy of Sciences, has successfully developed an autonomous microscopic ophthalmic surgical robot system that enhances the precision and safety of retinal injections, reducing iatrogenic injuries [1][3] Group 1: Technology Development - The autonomous microscopic ophthalmic surgical robot system can perform retinal and vascular injections within the entire intraocular space, significantly improving the accuracy and safety of fundus injections [1] - The system incorporates core algorithm modules for three-dimensional spatial perception during surgery, precise cross-scale positioning, and trajectory control, resulting in a substantial reduction in average positioning errors compared to manual and robotic-assisted surgeries performed by doctors [1] Group 2: Application Potential - Experts indicate that the application of autonomous surgical robot systems in ophthalmic procedures can enhance surgical safety through more intelligent and precise operational control, offering new possibilities for treating various ophthalmic diseases [3] - The technology shows significant potential for use in remote medical care and complex environments, highlighting its broad application prospects [3]

Core Viewpoint - The development of an autonomous microscopic ophthalmic surgical robot system by the Chinese Academy of Sciences aims to enhance the precision, safety, and consistency of intraocular procedures, addressing the challenges faced in delicate eye surgeries [1][2]. Group 1: Technological Advancements - The newly developed robot can autonomously perform subretinal and intravascular injections within the eye, significantly improving the accuracy and safety of retinal injections while minimizing iatrogenic damage [2][5]. - The research team has innovatively constructed core algorithm modules for three-dimensional spatial perception, precise cross-scale positioning, and trajectory control, enhancing the robot's operational capabilities [2][3]. Group 2: Clinical Validation - In experiments involving ocular prosthetics, ex vivo pig eyes, and live animal eyes, the robot achieved a 100% success rate in injections, with average positioning errors reduced by 79.87% compared to manual operations and 54.61% compared to doctor-assisted robotic operations, demonstrating superior safety and precision [5]. Group 3: Implications for the Industry - This research opens a new technological pathway for the autonomy of intraocular surgeries, potentially leading to intelligent and precise upgrades in ophthalmic surgical treatments, with significant applications in telemedicine and complex environments [6].

Core Viewpoint - The research team led by researcher Bian Guibin at the National Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation, Chinese Academy of Sciences, has successfully developed an autonomous ophthalmic surgical robot system, demonstrating its clinical feasibility [1] Group 1 - The system can autonomously perform subretinal and intravitreal injections throughout the entire intraocular space [1] - It significantly improves the accuracy, safety, and consistency of fundus injections, minimizing iatrogenic damage [1] - The robot assists surgeons in focusing more on surgical design and supervision tasks [1] Group 2 - The related findings were recently published in the journal Science Robotics [1]